Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer. Each patient will have 12 lead ECG prior, and daily during radiotherapy.
Collected data will be truly anonymised and individuals will no longer identifiable, and than evaluated for occurrence of atrial fibrillation. Inclusing Criteria: 1. Patients with radiotherapy for thoracic malignancy or breast cancer 2. Between 18-99 years-old Exclusion Criteria: 1. Patients with history of radiotherapy 2. Patients with history of atrial fibrillation 3. Patients with pacemaker implantation
Study Type
OBSERVATIONAL
Enrollment
400
12 lead ecg for each participant
Istanbul Faculty of Medicine
Fatih, Istanbul, Turkey (Türkiye)
Occurrence of atrial fibrillation
Occurrence of atrial fibrillation
Time frame: 1 day During radiotherapy
Onset time of atrial fibrillation
Onset time of atrial fibrillation
Time frame: 1 day During radiotherapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.